Publication | Closed Access
Serum calprotectin (S100A8/A9) levels as a new potential biomarker of treatment response in Hodgkin lymphoma
14
Citations
14
References
2021
Year
S100A8/A9 may be a potential biomarker for treatment response in HL independent of inflammation. This is the first study to investigate and show this finding. However, further large-scale studies are still required.
| Year | Citations | |
|---|---|---|
Page 1
Page 1